A Case Control Study to Evaluate the Impact of Colchicine on Patients Admitted to the Hospital with Moderate to Severe COVID-19 Infection

Table 1

Initial analysis on all patients who received colchicine and the patients meeting criteria for the control group, irrespective of the availability of two timepoint inflammatory markers. Age was nonnormally distributed; the Mann–Whitney U test was used to check for statistical significance. Fisher’s exact test was used to check for differences in the distribution of male patients in the two groups. The χ² test was used to evaluate for statistical significance of the difference in the intubated patients, patients expired, and patients discharged in the two groups.

	Colchicine group (n = 53)	Control group (n = 144)	value
Age (median)	70	65	0.049
Gender, male (percentage)	34 (64.2)	80 (55.6)	0.142
Intubated (percentage)	28 (52.8)	106 (73.6)	0.006
Discharged (percentage)	27 (50.9)	39 (27.1)	0.002
Expired (percentage)	26 (49.1)	105 (72.9)	0.002